The PE Ratio as of November 2024 (TTM) for Emmaus Life Sciences, Inc. (EMMA) is -0.39

According to Emmaus Life Sciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.39. This represents a change of -487.81% compared to the average of 0.10 of the last 4 quarters.

Emmaus Life Sciences, Inc. (EMMA) Historical PE Ratio (quarterly & annually)

How has EMMA PE Ratio performed in the past?

The mean historical PE Ratio of Emmaus Life Sciences, Inc. over the last ten years is 2.19. The current -0.39 PE Ratio has changed -1881.19% with respect to the historical average. Over the past ten years (40 quarters), EMMA's PE Ratio was at its highest in in the September 2023 quarter at 25.02. The PE Ratio was at its lowest in in the December 2020 quarter at -28.91.

Emmaus Life Sciences, Inc. (EMMA) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Emmaus Life Sciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Emmaus Life Sciences, Inc. (EMMA) Average PE Ratio

How has EMMA PE Ratio performed in the past?

The current PE Ratio of Emmaus Life Sciences, Inc. (EMMA) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Emmaus Life Sciences, Inc. (EMMA) PE Ratio vs. Peers

How is EMMA’s PE Ratio compared to its peers?

Emmaus Life Sciences, Inc.’s PE Ratio is greater than NRx Pharmaceuticals, Inc. (-0.68), less than Kaleido Biosciences, Inc. (0), greater than Applied Molecular Transport Inc. (-0.43), less than Scopus BioPharma Inc. (-0.00), less than Cell Source, Inc. (0), greater than Adhera Therapeutics, Inc. (-4.64), less than PolarityTE, Inc. (-0.00), less than ZIVO Bioscience, Inc. (0.16), greater than Anebulo Pharmaceuticals, Inc. (-5.20), greater than Adagene Inc. (-4.78), greater than Acrivon Therapeutics, Inc. Common Stock (-3.02), greater than AnaptysBio, Inc. (-3.24), greater than Mineralys Therapeutics, Inc. (-3.88), greater than null (-4.06),

Build a custom stock screener for Emmaus Life Sciences, Inc. (EMMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Emmaus Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Emmaus Life Sciences, Inc. (EMMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Emmaus Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.